Abstract
Artificial intelligence (AI) combined with magnetic resonance imaging (MRI) is transforming multiple sclerosis (MS) management. AI improves lesion detection, segmentation, and tracking, enhancing diagnostic precision and reducing variability. By integrating multimodal MRI data with biomarkers, AI-driven models predict disease progression and personalize treatment strategies, enabling early intervention. These models support therapy response prediction and optimize disease-modifying therapies. AI also automates longitudinal monitoring, assessing lesion changes, brain atrophy, and microstructural damage with high accuracy. Advanced techniques, such as radiomics and functional imaging, reveal subtle patterns of disease progression, providing valuable insights into neurodegeneration. These innovations streamline clinical workflows, improve patient outcomes, and advance precision medicine in MS. By enhancing diagnostic accuracy, treatment planning, and monitoring, AI-powered MRI represents a paradigm shift in neurodegenerative disease management